Axon Therapies Inc.
Splanchnic Ablation for Volume Management (SAVM) — a catheter-based ablation therapy targeting splanchnic nerves to reduce fluid retention in heart failure patients
- Sector
- Medtech
- Headquarters
- NEW YORK, NY
- Founded
- 2014
- Latest Form D
- $75M, Feb 2019
- Total capital
- $78.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $78.3M
- 3 Form D · last Feb 2019
- 93 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 8 pending · first 2019
- Rank in peer group#170 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$75M
- Private capital raisedForm D · SEC · 2nd filing$1.3M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#170 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Howard R. LevinResearcherExecutive Officer, DirectorLinked by 6 patents
- Andrew S. ElBardissiDirectorNamed in SEC Form D filings
- Imran S. EbaDirectorNamed in SEC Form D filings
- Mark R. GelfandExecutive Officer, DirectorNamed in SEC Form D filings
- Mitchell S. BloomExecutive OfficerNamed in SEC Form D filings
- Paul S. LaVioletteDirectorNamed in SEC Form D filings
Show all 7 people
- Steven S. HochbergDirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 21- GrantedMethods And Devices For Endovascular Ablation Of A Splanchnic NerveUSPTOUS 12,349,966
- PendingDevices And Methods For Treatment Of Heart Failure Via Electrical Modulation Of A Splanchnic NerveUSPTOApplication 18171972
- GrantedDevices And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationUSPTOUS 11,864,826
Show all 21 patent records
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveJul 8, 2025 · US 12,349,966Granted
- Devices And Methods For Treatment Of Heart Failure Via Electrical Modulation Of A Splanchnic NerveJan 25, 2024 · Application 18171972Pending
- Devices And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationJan 9, 2024 · US 11,864,826Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveDec 19, 2023 · US 11,844,569Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveNov 7, 2023 · US 11,806,073Granted
- Devices, Systems, And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationOct 31, 2023 · US 11,801,092Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveSep 12, 2023 · US 11,751,939Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveAug 1, 2023 · US 11,712,296Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveNov 22, 2022 · US 11,504,185Granted
- Devices And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationJul 5, 2022 · US 11,376,066Granted
- Devices, Systems, And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationOct 26, 2021 · US 11,154,354Granted
- Devices And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationFeb 9, 2021 · US 10,912,610Granted
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveFeb 18, 2020 · US 10,561,461Granted
- Devices And Methods For Treatment Of Heart Failure By Splanchnic Nerve AblationAug 13, 2019 · US 10,376,308Granted
- Devices And Methods For Treatment Of Heart FailureApplication 62162266Pending
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveApplication PCTUS2021014001Pending
- Methods, Devices And Systems For Treating A Patient By Gsn AblationApplication PCTUS2022032391Pending
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveApplication PCTUS2020038934Pending
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveApplication PCTUS2019015400Pending
- Methods And Devices For Endovascular Ablation Of A Splanchnic NerveApplication PCTUS2018066047Pending
- Devices And Methods For Treatment Of Heart FailureApplication 62240864Pending
Related companies, and why
- GENOMIND, INC.Similar federal contract value in Medtech · null in contracts
- SunBird BioSimilar federal contract value in Medtech · null in contracts
- GI DYNAMICS, INC.Similar federal contract value in Medtech · null in contracts
- Apreo Health, Inc.Similar federal contract value in Medtech · null in contracts
- METRITRACK, INC.Similar federal contract value in Medtech · null in contracts
- CARLSMED, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .